Blood monocyte activation in rheumatoid arthritis: Increased monocyte adhesiveness, integrin expression, and cytokine release

Clinical and Experimental Immunology

Volumn 106, Issue 1, 1996, Pages 13-19

  Liote F ^a,b   Boval Boizard, B ^b   Weill, D ^b   Kuntz, D ^a   Wautier, J L ^b  

^a CENTRE VIGGO PETERSEN   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Cell adhesion; Integrins; Monocyte; Rheumatoid arthritis; VLA antigen

Indexed keywords

BETA1 INTEGRIN; CD11 ANTIGEN; CYTOKINE; INTEGRIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ADHESION; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0029739990     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-820.x     Document Type: Article

References (46)

1. Ziff M. Role of endothelium in chronic inflammation. Springer Semin Immunopathol 1989; 11:199 214.
2. Harris ED, Jr. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990; 322:1277 88.
3. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994; 84:2068 101.
4. Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 1993; 11:767-804.
5. Pober JS. Cytokine-mediated activation of vaseular endothelium. Physiology and pathology. Am J Pathol 1984; 133:426 33.
6. Cutolo M, Sulli A, Barone A, Seriolo B, Accardo S. Macrophages, synovial tissue, and rheumatoid arthritis, Clin Exp Rheumatol 1993; 11:331 9.
7. Dustin ML, Rothlein R, Bahn AK, Dinarello CA, Springer TA. Induction of IL-1 and interferon-gamma: tissue distribution, biochemistry and function of a natural adherence molecule (ICAM-1). J Immunol 1986; 137:245 54.
8. de Fougerolles AR, Stacker SA, Schwarting R, Springer TA. Characterization of ICAM-2 and evidence for a third-counter-receptor for LFA-1. J Exp Med 1991; 174:253 67.
9. Fawcett J, Holness CL, Needham LA, Turley H, Gatter KC, Mason DY, Simmons DL. Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leucocytes. Nature 1992; 360:481-4.
10. de Fougerolles AR, Springer TA Intercellular adhesion molecule-3, a third adhesion counter-receptor for lymphocyte function-associated molecule-1 on resting lymphocytes. J Exp Med 1992; 175:185 90.
11. Carlos TA, Kovach NL, Schwartz BR, Rosa M, Newman B, Wayner E, Benjamin C, Oshorn L, Lobb R, Harlan J. Human monocytes bind to two cytokine-induced adhesive ligands on cultured human endothelial cells: endothelial-leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1. Blood 1991: 77:2266 71.
12. Elices MJ, Osborn L, Takada Y, Crouse C, Luhowsky S, Hemler ME, Lobb RR. VCAM-I on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4 fibronectin binding site. Cell 1990; 60:577 84.
13. Marlin SD, Springer TA. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen-1 (LFA-1). Cell 1987; 51:813 9.
14. Campanero MR, Del Pozo MA, Arroyo AG, Hernandex-Caselles T, Craig A, Pulido R, Sanchez-Madrid F. ICAM-3 interacts with LFA-1 and regulates the LFA-1/ICAM-1 cell adhesion pathway. J Cell Biol 1993; 123:1007-16.
15. El-Gabalawy H, Gallatin M, Vazeux R, Peterman G, Wilkins J. Expression of ICAM-R (ICAM-3). a novel counter-receptor for LFA-1, in rheumatoid and nonrheumatoid synovium. Arthritis Rheum 1994; 37:846-54.
16. Hemler ME. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol 1990; 8:365 80.
17. Liao H-X, Haynes BE. Role of adhesion molecules in the pathogenesis of rheumatoid arthritis. Rheum Dis N Am 1995; 21:715 40.
18. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH. Luthra HS et al. The American Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315 24.
19. Setiadi H, Wautier JL, Courillon-Mallet A, Passa P, Caen J. Increased adhesion to fibroneetin and Mo-1 expression by diabetic monocytes. J Immunol 1987; 138:3230 4.
20. Wautier JL, Pintigny D, Maclouf J, Wautier MP, Corvazier E, Caen J. Release of prostacyclin after erythrocyte adhesion to cultured vascular endothelium. J Lab Clin Med 1986; 107:210 5.
21. Weil D, Setiadi H, Wautier MP, Guillausseau PJ, Lioté F, Wautier JL. Pharmacological modulation of monocyte adhesion to endothelial cells. Clin Hemorheology 1992; 12:713 24.
22. Delomenie C, Wautier-Pepin MP, Chappey O, Wautier JL. Modulation of human endothelial cell activation by antiproliferative eytokines: exploration of arachidonic acid and intracellular cytokine pathways as possible mechanisms of action. Exp Cell Res 1993; 207:122 30.
23. Bath PMW, Booth RFG, Hassall DG. Monocyte lymphocyte discrimination in a new microtiter-based adhesion assay. J Immunol Meth 1989; 118:59 65.
24. Vlodavsky I, Liu GM, Hy-Al E., Gospodarowicz D. Platelet interaction with the extracellular matrix produced by cultured endothelial cells: a model to study the thrombogenicity of isolated subendothelial basal lamina. Thomb Res 1982; 28:179 91.
25. Higaki M, Miyasaka N, Sato K. Increased expression of CD11b (Mol) on peripheral blood monocytes of patients with rheumatoid arthritis. J Rheumatol 1992: 19:825 6 (letter).
26. Mazure G, Jayawardene SA, Perry JD, McCarthy D, Macey MG, Dumonde DC, Brown KA. Abnormal binding properties of blood monocytes in rheumatoid arthritis. Agents Actions 1993; 38:C41 3.
27. Bates PA, Berendt A, Bennet R, Cabanas C, Craig A, Harvey J, McDonald A, Hogg N. Leukocyte integrin activation. Path Biol 1992; 40: 785 8.
28. Allen CA, Highton J, Palmer DG. Increased expression of p150,95 and CR3 leukocyte adhesion molecules by mononuclear phagocytes in rheumatoid synovial membranes. Arthritis Rheum 1989; 32:947 54.
29. 1 (CD29) integrin expression in rheumatoid synovial membranes: an immunohistologic study of distribution patterns. J Rheumatol 1993; 20:231 7.
30. Koch AE, Burrows JC, Haines KG, Carlos TM, Harlan JM, Joseph S, Leibovitch S. Immunolocalization of endothelial and leucocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues. Lab Invest 1991; 64:313 20.
31. Diaz-Gonzales F, Gonzales-Alvaro I, Campanez MR, Mollinedo F, del Pozo MA, Munoz C, Pivel JP. Sanchez-Madrid F. Prevention of in vitro neutrophil-endothelium attachment through shedding of L-selectin by nonsteroidal antiinflammatory drugs. J Clin Invest 1995; 95:1756 65.
32. Veale D, Yanni G, Rogers S, Barnes I., Bresnihan B, Fitzgerald O. Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum 1993; 36:893 900.
33. Abbot SE, Kaul A, Stevens CR, Blake DR. Isolation and characterization of synovial microvascular cells. Characterization and assessment of adhesion molecule expression. Arthritis Rheum 1992; 35:401 6.
34. Grober JS, Bowen BL, Ebling H, Athey B, Thompson CB, Fox DA, Stoolman LM. Monocyte-endothelial adhesion in chronic rheumatoid arthritis. In Situ detection of selectin and integrin-dependent interactions. J Clin Invest 1993; 91:2609 19.
35. Corkill MM, Kirkham BW, Haskard DO, Barabtis C, Gobson T, Panayi GS. Gold treatment of rheumatoid arthritis decreases synovial expression of the endothelial leukocyte adhesion receptor ELAM-1. J Rheumatol 1991; 18:1453 60.
36. Trezzini C, Schuepp B, Maly FE, Jungi TW. Evidence that exposure to fibrinogen or to antibodies directed against Mac-1 (CD11b CD18; CR3) modulates human monocyte effector functions. Br J Hematol 1991; 77:16 24.
37. Horsburg CR, Clark RAF, Kirkpatrick CH. Lymphokines and platelets promote human monocyte adherence to fibrinogen and fibronectin in vitro. J Leukocyte Biol 1987; 41:14 24.
38. Hosein B, Bianco C. Monocyte receptors tor fibronectin characterized by a monoclonal antibody that interferes with receptor activity. J Exp Med 1985; 162:157 70.
39. Brown DL, Phillips DR, Damsky CH, Charo IF. Synthesis and expression of the fibroncetin receptor in human monocytes. J Clin Invest 1989; 84:366 70.
40. Laffon A, Garcia-Vicuna R, Humbria A, Postigo AA, Corbi AL. de Lans-Dazuri MO, Sanchez-Madrid F. Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis. J Clin Invest 1991; 88:546 52.
41. Shore A, Jaglal S, Keystone EC. Enhanced interleukin 1 generation by monocytes in vitro is temporally linked to an early event in the onset or exacerbation of rheumatoid arthritis. Clin Exp Immunol 1986; 65:293 302.
42. Ruschen S, Stellberg W, Warnatz H. Kinetics of cytokine secretion by mononuclear cells of the blood from rheumatoid arthritis patients are different from those of healthy controls. Clin Exp Immunol 1992; 89:32 7.
43. Leirisalo-Repo M, Paimela L, Jäättelä M, Koskimies S, Repo H. Production of TNF by monocytes of patients with early rheumatoid arthritis is increased. Scand J Rheumatol 1995; 24:366-371.
44. Al-Jaandi M, Al-Dalaan A, Al-Balla S, Raziuddin S. CD4 T cell inducible immunoregulatory cytokine response in rheumatoid arthritis. J Rheumatol 1996; 23:809 14.
45. Hahn G, Stuhlmuller B, Hain N, Kalden JR, Pfizenmaier K, Burmester GR. Modulation of monocyte activation in patients with rheumatoid arthritis by leukopheresis therapy. J Clin Invest 1993; 91:862-70.
46. Horneff G, Sack U, Kalden JR, Emmrich F, Burmester GR. Reduction of monocyte-macrophage activation markers upon anti-CD4 treatment. Decreased levels of IL-1, IL-6, neopterin and soluble CD14 in patients with rheumatoid arthritis. Clin Exp Immunol 1993; 91:207-13.